HER2/neu Vaccine Results Spurs Phase III Planning By Apthera, Inc.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Col. George E. Peoples, M.D., Chief of Surgical Oncology at Brooke Army Medical Center in San Antonio, TX will be presenting the results of a 200 patient Phase II study of a HER2/neu vaccine (E75) for the prevention of recurrence in high risk breast cancer patients at the 29th Annual San Antonio Breast Cancer Symposium, the premier breast cancer educational and scientific event. Dr. Peoples will present positive interim analysis of the Phase II study of E75 on Thursday, December 14th at 10:30am (CST) at the Georgia and Henry B. Gonzalez Convention Center in San Antonio, Texas.
MORE ON THIS TOPIC